Literature DB >> 2913081

Feelings of stigmatization in patients with psoriasis.

I H Ginsburg1, B G Link.   

Abstract

The concept of stigma, defined as a discrediting mark that sets a person off from others, is used in a systematic, in-depth examination of how 100 adults with psoriasis experience their illness. Information on demographic and illness variables that might predict feelings of being stigmatized were obtained. Through factor analysis of a specially designed questionnaire, six dimensions of the stigma experience were identified: anticipation of rejection, feeling of being flawed, sensitivity to others' attitudes, guilt and shame, secretiveness, and positive attitudes. There was marked variability in the presence and magnitude of these feelings. Different predictors emerged for different dimensions of the stigma experience, the most frequent being age at onset, extent of bleeding, employment status, duration, and rejection experience. Of all the aspects of the illness, bleeding proved the strongest predictor of stigma feelings and of despair, which correlates highly with stigma. Despair and feeling stigmatized may lead to noncompliance with treatment, possibly worsening the status of the psoriasis.

Entities:  

Mesh:

Year:  1989        PMID: 2913081     DOI: 10.1016/s0190-9622(89)70007-4

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  39 in total

Review 1.  Psychocutaneous disorders.

Authors:  D G Folks; J K Warnock
Journal:  Curr Psychiatry Rep       Date:  2001-06       Impact factor: 5.285

Review 2.  Update on the natural history and systemic treatment of psoriasis.

Authors:  Stephen K Richardson; Joel M Gelfand
Journal:  Adv Dermatol       Date:  2008

Review 3.  Patient-Reported Outcome Instruments for Surgical and Traumatic Scars: A Systematic Review of their Development, Content, and Psychometric Validation.

Authors:  Lily R Mundy; H Catherine Miller; Anne F Klassen; Stefan J Cano; Andrea L Pusic
Journal:  Aesthetic Plast Surg       Date:  2016-06-29       Impact factor: 2.326

4.  Dyadic adjustment, family coping, body image, quality of life and psychological morbidity in patients with psoriasis and their partners.

Authors:  M Graça Pereira; Laura Brito; Tom Smith
Journal:  Int J Behav Med       Date:  2012-09

5.  The relationship between demographic and clinical variables, and quality of life aspects in patients with psoriasis.

Authors:  A Wahl; T Moum; B R Hanestad; I Wiklund
Journal:  Qual Life Res       Date:  1999-06       Impact factor: 4.147

6.  Cost-effectiveness of treatment with etanercept for psoriasis in Sweden.

Authors:  Christopher Knight; Josephine Mauskopf; Mats Ekelund; Amitabh Singh; Shiyi Yang; Robert Boggs
Journal:  Eur J Health Econ       Date:  2011-03-06

Review 7.  Psychosocial effect of common skin diseases.

Authors:  Benjamin Barankin; Joel DeKoven
Journal:  Can Fam Physician       Date:  2002-04       Impact factor: 3.275

8.  Attentional bias for psoriasis-specific and psychosocial threat in patients with psoriasis.

Authors:  Dónal G Fortune; Helen L Richards; Alan Corrin; Robert J Taylor; Christopher E Griffiths; Chris J Main
Journal:  J Behav Med       Date:  2003-06

9.  Disease Severity, Quality of Life, and Psychiatric Morbidity in Patients With Psoriasis With Reference to Sociodemographic, Lifestyle, and Clinical Variables: A Prospective, Cross-Sectional Study From Lahore, Pakistan.

Authors:  Abdul Rahman Khawaja; Syed Muhammad Azam Bokhari; Rasheed Tariq; Shahzad Atif; Hanif Muhammad; Qadeer Faisal; Mohammad Jafferany
Journal:  Prim Care Companion CNS Disord       Date:  2015-06-25

10.  Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasis.

Authors:  Jina Chung; Kristina Callis Duffin; Junko Takeshita; Daniel B Shin; Gerald G Krueger; Andrew D Robertson; Andrea B Troxel; Abby S Van Voorhees; Emily Edson-Heredia; Joel M Gelfand
Journal:  J Am Acad Dermatol       Date:  2014-06-02       Impact factor: 11.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.